Compare MOLN & KRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MOLN | KRMD |
|---|---|---|
| Founded | 2004 | 1980 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 157.8M | 186.3M |
| IPO Year | 2021 | N/A |
| Metric | MOLN | KRMD |
|---|---|---|
| Price | $3.98 | $5.49 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | $3.75 | ★ $5.13 |
| AVG Volume (30 Days) | 3.5K | ★ 201.0K |
| Earning Date | 10-30-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $39,070,637.00 |
| Revenue This Year | N/A | $23.36 |
| Revenue Next Year | $1,000.00 | $18.63 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 22.12 |
| 52 Week Low | $3.36 | $1.86 |
| 52 Week High | $5.91 | $6.11 |
| Indicator | MOLN | KRMD |
|---|---|---|
| Relative Strength Index (RSI) | 55.40 | 64.27 |
| Support Level | $3.98 | $5.44 |
| Resistance Level | $4.40 | $5.88 |
| Average True Range (ATR) | 0.18 | 0.35 |
| MACD | -0.01 | -0.05 |
| Stochastic Oscillator | 68.12 | 76.25 |
Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).